Yahoo Web Search

We expect Johnson & Johnson JNJ, a healthcare bellwether, to beat expectations when it reports first-quarter 2018 results on April 17, before market opens. Last quarter, the company ...

Pharmaceutical Co. is pursuing Shire Plc in a deal that could approach $50 billion, Sanofi agreed in January to a 64 percent premium in its $11.6 billion deal for Bioverativ Inc. and ...

With that as the backdrop, here’s a rundown of the market’s highest-quality dividend stocks … dividend payers that could be considered the aristocrats among the market’s income-oriented investments ...

(NASDAQ: GRMN), one of the leading healthcare companies in the world in Johnson & Johnson (NYSE: JNJ), and high-growth, high-yield Pattern Energy Group Inc (NASDAQ: PEGI ...

DWS, the newly renamed exchange traded funds arm of Deutsche Bank AG (NYSE: DB), expanded its ETF roster Thursday with the debut of the Xtrackers Russell 1000 US QARP ETF (NYSE: QARP). The new ...

After a spell of high volatility driven by uncertainty over global trade policy and the threat of rise in prices of essential commodities, Wall Street is looking for some respite in the upcoming ...

The healthcare industry is entering a period of significant changes. Software and new technologies are gradually beginning to revolutionize the industry. To bring a successful drug on the market ...